1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-53. doi:10.1002/ijc.31937 PMid:30350310

2. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66(6):1192-308.doi:10.1093/jnci/66.6.1192

3. Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411(6835):390-5. doi:10.1038/35077256 PMid:11357148

4. Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008; 25(9): 2097-116. doi:10.1007/s11095-008-9661-9 PMid:18626751 PMCid:PMC2515569

5. Heitz AE, Baumgartner RN, Baumgartner KB, Boone SD. Healthy lifestyle impact on breast cancer-specific and all-cause mortality. Breast Cancer Res Treat. 2018;167(1):171-81. doi:10.1007/s10549-017-4467-2 PMid:28861753 PMCid:PMC5830105

6. Gezici S. Comparative anticancer activity analysis of saffron extracts and a principle component, crocetin for prevention and treatment of human malignancies. J Food Sci Technol. 2019;56(12):5435-43. doi:10.1007/s13197-019-04014-y PMid:31749491 PMCid:PMC6838258

7. Lee BM, Park KK. Beneficial and adverse effects of chemopreventive agents. Mutat Res. 2003;523:265-78.doi:10.1016/S0027-5107(02)00342-1 PMid:12628524

8. Sanaei M, Kavoosi F, Arabloo M. Effect of Curcumin in Comparison with Trichostatin A on the Reactivation of Estrogen Receptor Alpha gene Expression, Cell Growth Inhibition and Apoptosis Induction in Hepatocellular Carcinoma Hepa 1-6 Cell lLine. Asian Pac J Cancer Prev. 2020;21(4):1045-50. doi:10.31557/APJCP.2020.21.4.1045 PMid:32334468 PMCid:PMC7445996

9. Evans WC. Trease and Evans' pharmacognosy: Elsevier Health Sciences; 2009.

10. Fleming T. PDR for herbal medicines: Medical Economics Company; 1998.

11. Huang KC. The pharmacology of Chinese herbs: CRC press; 1998. doi:10.4324/9780367801892

12. Duke JA. Handbook of medicinal herbs: CRC press; 2010.

13. Sweetman S, Martindale I. The Complete Drug Reference Pharmaceutical Press. London, UK. 2002.

14. Abe K, Saito H. Effects of saffron extract and its constituent crocin on learning behaviour and long‐term potentiation. Phytother Res. 2000;14(3):149-52. doi:10.1002/(SICI)1099-1573(200005)14:3<149::AID-PTR665>3.0.CO;2-5

15. D'Amelio Sr FS. Botanicals: A phytocosmetic desk reference: CRC Press; 1998. doi:10.1201/9781420049329

16. Khanali M, Shahvarooghi Farahani S, Shojaei H, Elhami B. Life cycle environmental impacts of saffron production in Iran. Environ Sci Pollut Res Int. 2017; 24(5): 4812-21. doi:10.1007/s11356-016-8228-2 PMid:27987119

17. Gohari AR, Saeidnia S, Mahmoodabadi MK. An overview on saffron, phytochemicals, and medicinal properties. Pharmacogn Revi. 2013; 7(13):61. doi:10.4103/0973-7847.112850 PMid:23922458 PMCid:PMC3731881

18. Kamalipour M, Akhondzadeh S. Cardiovascular effects of saffron: An evidence-based review. J Tehran Heart Center. 2011;6(2):59.

19. Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wiener Medizinische Wochenschrift. 2007; 157(13-14): 315-9. doi:10.1007/s10354-007-0428-4 PMid:17704979

20. Mokhtarian R, Rajabi S, Zahedian S, Jafarinejad-Farsangi S, Hadizadeh M, Sadeghinejad M. The effect of saffron and its extracts on the treatment of breast cancer: A narrative review. Ann Pharmaceutiq Franç. 2024;82(4):629-40 doi:10.1016/j.pharma.2024.02.011 PMid:38367937

21. Abdullaev F. Biological effects of saffron. BioFactors (Oxford, England). 1993;4(2):83-6.

22. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Experimental Biology and Medicine. 2002;227(1):20-5. doi:10.1177/153537020222700104PMid:11788779

23. Rios J, Recio M, Giner R, Manez S. An update review of saffron and its active constituents. Phytother Res. 1996;10(3):189-93. doi:10.1002/(SICI)1099-1573(199605)10:3<189::AID-PTR754>3.0.CO;2-C

24. Winterhalter P, Straubinger M. Saffron-renewed interest in an ancient spice. Food Rev Int. 2000;16(1):39-59. doi:10.1081/FRI-100100281

25. Tarantilis PA, Polissiou MG. Isolation and identification of the aroma components from saffron (Crocus sativus). J Agric Food Chem. 1997;45(2):459-62. doi:10.1021/jf960105e

26. Deo B. Growing saffron-the world's most expensive spice. Crop Food Res. 2003;20(1):1-4.

27. Sampathu S, Shivashankar S, Lewis Y, Wood A. Saffron (Crocus sativus Linn.)-Cultivation, processing, chemistry and standardization. Critical Reviews in Food Sci Nutr. 1984; 20(2): 123-57. doi:10.1080/10408398409527386

28. Gregory MJ, Menary RC, Davies NW. Effect of drying temperature and air flow on the production and retention of secondary metabolites in saffron. J Agric Food Chem. 2005;53(15):5969-75. doi:10.1021/jf047989j PMid:16028982

29. Assimopoulou A, Sinakos Z, Papageorgiou V. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res. 2005;19(11):997-1000. doi:10.1002/ptr.1749 PMid:16317646

30. Alonso G, Salinas M, Garijo J, Sánchez‐Fernández M. Composition of crocins and picrocrocin from Spanish saffron (Crocus sativus L.). J Food Qual. 2001;24(3):219-33. doi:10.1111/j.1745-4557.2001.tb00604.x

31. Shakeri M, Hashemi Tayer A, Shakeri H, Sotoodeh Jahromi A, Moradzadeh M, Hojjat-Farsangi M. Toxicity of Saffron Extracts on Cancer and Normal Cells: A Review Article. Asian Pac J Cancer Prev. 2020;21(7):1867-75. doi:10.31557/APJCP.2020.21.7.1867 PMid:32711409 PMCid:PMC7573418

32. Abdullaev F, Espinosa-Aguirre J. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev. 2004;28(6):426-32. doi:10.1016/j.cdp.2004.09.002 PMid:15582266

33. Melnyk JP, Wang S, Marcone MF. Chemical and biological properties of the world's most expensive spice: Saffron. Food Res Int. 2010;43(8):1981-9. doi:10.1016/j.foodres.2010.07.033

34. Zeinali M, Zirak MR, Rezaee SA, Karimi G, Hosseinzadeh H. Immunoregulatory and anti-inflammatory properties of Crocus sativus (Saffron) and its main active constituents: A review. Iran J Basic Med Sci. 2019;22(4):334-44.

35. Hosseini A, Razavi BM, Hosseinzadeh H. Saffron (Crocus sativus) petal as a new pharmacological target: a review. Iran J Basic Med Sci. 2018;21(11):1091-9.

36. Mani R, Natesan V. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry. 2018;145:187-96. doi:10.1016/j.phytochem.2017.09.016 PMid:29161583

37. Lecomte S, Demay F, Ferrière F, Pakdel F. Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects? Int J Mol Sci. 2017;18(7). doi:10.3390/ijms18071381 PMid:28657580 PMCid:PMC5535874

38. Abdullaev F, Frenkel G. The effect of saffron on intracellular DNA, RNA and protein synthesis in malignant and non-malignant human cells. BioFactors (Oxford, England). 1992;4(1):43-5. doi:10.1016/0304-3835(92)90211-D PMid:1511408

39. Nair SC, Kurumboor S, Hasegawa J. Saffron chemoprevention in biology and medicine: a review. Cancer Biother Radiopharm. 1995;10(4):257-64. doi:10.1089/cbr.1995.10.257 PMid:8590890

40. Tarantilis P, Morjani H, Polissiou M, Manfait M. Inhibition of growth and induction of differentiation of promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus L. Anticancer Res. 1994;14(5A):1913-8.

41. Abdullaev FI. Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicol Lett. 1994; 70(2): 243-51. doi:10.1016/0378-4274(94)90168-6 PMid:8296327

42. Abdullaev F, Frenkel G. Effect of saffron on cell colony formation and cellular nucleic acid and protein synthesis. BioFactors (Oxford, England). 1992;3(3): 201-4.

43. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004; 134(12):3479S-85S. doi:10.1093/jn/134.12.3479S PMid:15570057

44. Tavakkol-Afshari J, Brook A, Mousavi SH. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol. 2008;46(11):3443-7. doi:10.1016/j.fct.2008.08.018 PMid:18790714

45. Samarghandian S, Borji A, Farahmand SK, Afshari R, Davoodi S. Crocus sativus L.(Saffron) Stigma Aqueous Extract Induces Apoptosis in Alveolar Human Lung Cancer Cells through Caspase-Dependent Pathways Activation. Biomed Res Int. 2013;2013. doi:10.1155/2013/417928 PMid:24288678 PMCid:PMC3830877

46. Abdullaev F, Riveron-Negrete L, Caballero-Ortega H, Manuel Hernández J, Perez-Lopez I, Pereda-Miranda R, et al. Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). Toxicol in Vitro. 2003;17(5):731-6. doi:10.1016/S0887-2333(03)00098-5 PMid:14599470

47. Molnar J, Szabo D, Pusztai R, Mucsi I, Berek L, Ocsovszki I, et al. Membrane associated antitumor effects of crocine-, ginsenoside-and cannabinoid derivates. Anticancer Res. 1999;20(2A):861-7.

48. Escribano J, Piqueras A, Medina Jn, Rubio A, Alvarez-Ortı́ M, Fernández JA. Production of a cytotoxic proteoglycan using callus culture of saffron corms (Crocus sativus L.). J Biotechnol. 1999; 73 (1): 53-9. doi:10.1016/S0168-1656(99)00125-X PMid:10483114

49. Escribano J, Dı́az-Guerra MJM, Riese HH, Ontañón J, Garcı́a-Olmo D, Garcı́a-Olmo DC, et al. In vitro activation of macrophages by a novel proteoglycan isolated from corms of Crocus sativus L. Cancer Lett. 1999;144(1):107-14. doi:10.1016/S0304-3835(99)00211-6 PMid:10503884

50. Akbarpoor V, Karimabad MN, Mahmoodi M, Mirzaei MR. The saffron effects on expression pattern of critical self-renewal genes in adenocarcinoma tumor cell line (AGS). Gene Rep. 2020;19:100629.doi:10.1016/j.genrep.2020.100629

51. Escribano J, Alonso G-L, Coca-Prados M, Fernández J-A. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett. 1996;100(1):23-30. doi:10.1016/0304-3835(95)04067-6 PMid:8620447

52. Salomi M, Nair S, Panikkar P, editors. Cytotoxicity and non-mutagenicity of Nigela sativa and saffron (Crocus sativus) in vitro. Proc Ker Sci Congr; 1991.

53. Morjani H, Tarantilis P, Polissiou M, Manfait M. Growth inhibition and induction of crythroid differentiation activity by crocin, dimethylcrocetine and b-carotene on K562 tumor cells. Anticancer Res. 1990;10:1398-406.

54. Garc-Olmo DC, Riese HH, Escribano J, Onta˜' n J, Fernandez JA, Atiénzar M, et al. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rat. Nutr Cancer. 1999; 35(2): 120-6. doi:10.1207/S15327914NC352_4 PMid:10693164

55. Noureini SK, Wink M. Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation. Asian Pac J Cancer Prev. 2012;13(5):2305-9. doi:10.7314/APJCP.2012.13.5.2305 PMid:22901211

56. Aung H, Wang C, Ni M, Fishbein A, Mehendale S, Xie J, et al. Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol. 2007;29(3):175.

57. Mehri S, Abnous K, Mousavi SH, Shariaty VM, Hosseinzadeh H. Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells. Cell Mol Neurobiol. 2012;32(2):227-35. doi:10.1007/s10571-011-9752-8 PMid:21901509

58. Ebrahim‐Habibi MB, Amininasab M, Ebrahim‐Habibi A, Sabbaghian M, Nemat‐Gorgani M. Fibrillation of α‐lactalbumin: Effect of crocin and safranal, two natural small molecules from Crocus sativus. Biopolymers. 2010;93(10):854-65. doi:10.1002/bip.21477 PMid:20564050

59. Salomi M, Nair SC, Panikkar K. Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. 1991. doi:10.1080/01635589109514142 PMid:1923908

60. Martin G, Goh E, Neff A. Evaluation of the developmental toxicity of crocetin on Xenopus. Food Chem Toxicol. 2002;40(7):959-64. doi:10.1016/S0278-6915(02)00040-6 PMid:12065218

61. Jagadeeswaran R, Thirunavukkarasu C, Gunasekaran P, Ramamurty N, Sakthisekaran D. In vitro studies on the selective cytotoxic effect of crocetin and quercetin. Fitoterapia. 2000;71(4):395-9. doi:10.1016/S0367-326X(00)00138-6PMid:10925010

62. Chryssanthi DG, Lamari FN, Iatrou G, Pylara A, Karamanos NK, Cordopatis P. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res. 2007;27 (1A):357-62.

63. Mousavi SH, Tavakkol-Afshari J, Brook A, Jafari-Anarkooli I. Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food Chem Toxicol. 2009;47(8):1909-13. doi:10.1016/j.fct.2009.05.017 PMid:19457443

64. Kanakis CD, Tarantilis PA, Tajmir-Riahi H-A, Polissiou MG. Interaction of tRNA with safranal, crocetin, and dimethylcrocetin. J Biomol Struct Dyn. 2007;24(6):537-45. doi:10.1080/07391102.2007.10507142 PMid:17508775

65. Wang CJ, Shiah HS, Lin JK. Modulatory effect of crocetin on aflatoxin B cytotoxicity and DNA adduct formation in C3H10T12 fibroblast cell. Cancer Lett. 1991;56(1):1-10. doi:10.1016/0304-3835(91)90186-L PMid:1900736

66. Wang CJ, Shiow SJ, Lin JK. Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats. Carcinogenesis. 1991;12(3):459-62. doi:10.1093/carcin/12.3.459 PMid:1672627

67. Chang W, Lin Y, Lee M, Shiow S, Wang C. Inhibitory effect of crocetin on benzo (a) pyrene genotoxicity and neoplastic transformation in C3H10T1/2 cells. Anticancer Res. 1995;16(6B):3603-8. doi:10.1093/carcin/16.2.187 PMid:7859347

68. Tseng TH, Chu CY, Huang JM, Shiow S-J, Wang C-J. Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Lett 1995;97(1):61-7 doi:10.1016/0304-3835(95)03964-X PMid:7585479

69. Dhar A, Mehta S, Dhar G, Dhar K, Banerjee S, Van Veldhuizen P, et al. Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. Mol Cancer Ther. 2009;8(2):315-23.doi:10.1158/1535-7163.MCT-08-0762 PMid:19208826

70. G Gutheil W, Reed G, Ray A, Anant S, Dhar A. Crocetin: an agent derived from saffron for prevention and therapy for cancer. Curr Pharm Biotechnol 2012; 13(1):173-9. doi:10.2174/138920112798868566 PMid:21466430 PMCid:PMC4461363

71. Mousavi SH, Tayarani NZ, Parsaee H. Protective effect of saffron extract and crocin on reactive oxygen species-mediated high glucose-induced toxicity in PC12 cells. Cell Mol Neurobiol. 2010;30(2):185-91. doi:10.1007/s10571-009-9441-z PMid:19711182

72. Ashrafi M, Bathaie S, Taghikhani M, Moosavi-Movahedi A. The effect of carotenoids obtained from saffron on histone H1 structure and H1-DNA interaction. Int J Biol Macromol. 2005;36(4):246-52.doi:10.1016/j.ijbiomac.2005.05.008 PMid:16087230

73. Rahiman N, Akaberi M, Sahebkar A, Emami SA, Tayarani-Najaran Z. Protective effects of saffron and its active components against oxidative stress and apoptosis in endothelial cells. Microvasc Res. 2018;118:82-9. doi:10.1016/j.mvr.2018.03.003 PMid:29524452

74. Prem-kumar K. Abraham SK, Santhiya ST, Ramesh A (2003). Protective effects of saffron (Crocus sativus L.) on genotoxin induced oxidative stress in Swiss albini mice. Phytother Res.17(6):614-7. doi:10.1002/ptr.1209 PMid:12820227

75. Nair S, Salomi M, Varghese C, Panikkar B, Panikkar K. Effect of saffron on thymocyte proliferation, intracellular glutathione levels and its antitumor activity. BioFactors (Oxford, England). 1992;4(1):51-4.

76. Nair S, Pannikar B, Panikkar K. Antitumour activity of saffron (Crocus sativus). Cancer Lett. 1991; 57(2):109-14. doi:10.1016/0304-3835(91)90203-T PMid:2025883

77. El Daly E. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. Journal de pharmacie de Belgique. 1997;53(2):87-93.

78. Bathaie SZ, Miri H, Mohagheghi M-A, Mokhtari-Dizaji M, Shahbazfar A-A, Hasanzadeh H. Saffron aqueous extract inhibits the chemically-induced gastric cancer progression in the wistar albino rat. Iran J Basic Med Sci. 2013;16(1):27.

79. Nair SC, Salomi M, Panikkae B, Panikkar K. Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice. J Ethnopharmacol. 1991;31(1):75-83. doi:10.1016/0378-8741(91)90146-5 PMid:2030595

80. Nair S, Panikkar K, Parthod R. Protective effects of crocetin on the bladder toxicity induced by cyclophosphamide. Cancer Biother Radiopharm. 1993;8(4):339-43. doi:10.1089/cbr.1993.8.339 PMid:7804375

81. Nair S, Varghese CD, Paniker K, Kurumboor S, Parathod R. Effects of saffron on Vitamin A levels and its Antitumour activity on the growth of solid tumours in mice. Pharm Biol 1994;32(2):105-14. doi:10.3109/13880209409082981

82. Premkumar K, Abraham SK, Santhiya S, Gopinath P, Ramesh A. Inhibition of genotoxicity by saffron (Crocus sativus L.) in mice. Drug Chem Toxicol. 2001;24(4):421-8. doi:10.1081/DCT-100106266 PMid:11665650

83. Hariri AT, Moallem SA, Mahmoudi M, Hosseinzadeh H. The effect of crocin and safranal, constituents of saffron, against subacute effect of diazinon on hematological and genotoxicity indices in rats. Phytomedicine. 2011;18(6):499-504. doi:10.1016/j.phymed.2010.10.001 PMid:21036580

84. Wang CJ, Cheng TC, Liu JY, Chou FP, Kuo ML, Lin JK. Inhibition of protein kinase C and proto‐oncogene expression by crocetin in NIH/3T3 cells. Mol Carcinogen. 1996;17(4):235-40. doi:10.1002/(SICI)1098-2744(199612)17:4<235::AID-MC7>3.0.CO;2-C

85. Wang CJ, Hsu JD, Lin JK. Suppression of aflatoxin B1-induced hepatotoxic lesions by crocetin (a natural carotenoid). Carcinogenesis. 1991;12(10):1807-10. doi:10.1093/carcin/12.10.1807 PMid:1934261

86. Magesh V, Singh JPV, Selvendiran K, Ekambaram G, Sakthisekaran D. Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol Cell Biochem. 2006;287(1-2):127-35.doi:10.1007/s11010-005-9088-0 PMid:16685462

87. Magesh V, DurgaBhavani K, Senthilnathan P, Rajendran P, Sakthisekaran D. In vivo protective effect of crocetin on benzo (a) pyrene‐induced lung cancer in Swiss albino mice. Phytother Res. 2009;23(4):533-9. doi:10.1002/ptr.2666 PMid:19067387

88. Gainer J, Wallis D, Jones J. The effect of crocetin on skin papillomas and Rous sarcoma. Oncology. 1976; 33(5-6):222-4. doi:10.1159/000225150 PMid:194195

89. Mathews-Roth M. Antitumor activity of β-carotene, canthaxanthin and phytoene. Oncology. 1982; 39(1):33-7. doi:10.1159/000225601 PMid:6799883

90. Wichtl M. Herbal drugs and phytopharmaceuticals: a handbook for practice on a scientific basis: Medpharm GmbH Scientific Publishers; 2004.

91. Karimi GR, Hosseinzadeh H, Khalegh PP. Study of antidepressant effect of aqueous and ethanolic extract of Crocus sativus in mice. Iran J Basic Med Sci. 2001.

92. Lucas CD, Hallagan JB, Taylor SL. The role of natural color additives in food allergy. Ad Food Nutr Res. 2000;43:195-216. doi:10.1016/S1043-4526(01)43005-1 PMid:11285683

93. Hosseinzadeh H, Shakib SS, Sameni AK, Taghiabadi E. Acute and Subacute Toxicity of Safranal, a Constituent of Saffron, in Mice and Rats. Iran J Pharmaceutical Res. 2013;12(1):93.

94. Hosseinzadeh H, Shariaty M, Khadem-Sameni A, Vahabzadeh M, Ríos J, Recio M. Acute and sub-acute toxicity of crocin, a constituent of Crocus sativus L.(saffron), in mice and rats. Pharmacologyonline. 2010;2:943-51.

95. Modaghegh MH, Shahabian M, Esmaeili HA, Rajbai O, Hosseinzadeh H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine. 2008;15(12):1032-7. doi:10.1016/j.phymed.2008.06.003 PMid:18693099

96. Colapietro A, Mancini A, D'Alessandro AM, Festuccia C. Crocetin and Crocin from Saffron in Cancer Chemotherapy and Chemoprevention. Anticancer Agents Med Chem. 2019;19(1):38-47. doi:10.2174/1871520619666181231112453 PMid:30599111

97. Loomis TA, Hayes AW. Loomis's essentials of toxicology: Academic Press; 1996. doi:10.1016/B978-012455625-6/50014-3

98. Kennedy GL, Ferenz RL, Burgess BA. Estimation of acute oral toxicity in rates by determination of the approximate lethal dose rather than the LD50. J Appl Toxicol. 1986;6(3):145-8. doi:10.1002/jat.2550060302 PMid:3722708

99. Khorasanchi Z, Shafiee M, Kermanshahi F, Khazaei M, Ryzhikov M, Parizadeh MR, et al. Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties. Phytomedicine. 2018;43:21-7 doi:10.1016/j.phymed.2018.03.041 PMid:29747750